TBA-7371-CL001 ; Phase 1, Partially-Blind, Placebo Controlled Randomized, Combined SAD With Food Effect Cohort and MAD and DDI Study to Evaluate Safety, Tolerability, PK and PK Interaction Between TBA-7371 With Midazolam and Bupropion in Healthy Subjects.

Study Director
Paul Bruinenberg, MD
Start Date
8 / 2017
Trial Phase
Phase I
Trial Status
in data analysis
Current Enrollment
74 July 2018
Target Enrollment
Last Update Posted: February 8, 2018 in

Listed as completed July 8, 2018.

Developer Associations
Compound Associations